Skip to main content
. 2019 Sep 4;85(11):2568–2579. doi: 10.1111/bcp.14078

Figure 6.

Figure 6

Simulated pevonedistat concentration–time profiles at the recommended clinical dose of 20 mg/m2 administered on days 1, 3 and 5. Note: Black solid line is the median simulated concentration; black dashed lines are the lower 5th and upper 95th percentiles of the simulated data; grey shaded areas are the 95% confidence intervals for each percentile